EU regulator likely to fine J&J, Novartis next month - sources
BRUSSELS Nov 22 (Reuters) - EU antitrust regulators are set to fine drugmakers Johnson & Johnson and Novartis next month for blocking the sale of a cheaper generic painkiller in the Netherlands, two people familiar with the matter said on Friday.
"The European Commission is likely to issue a decision next month," one of the people said.
In its charge sheet sent to the companies in January, the European Union competition watchdog said the so-called "pay-for-delay" deal against the generic versions of fentanyl hurt Dutch consumers and healthcare providers.
Commission spokesman for competition policy, Antoine Colombani, declined to comment. Johnson & Johnson and Novartis were not immediately available for comment.
- Exclusive: Malaysia plane probe narrows on mid-air disintegration - source
- Radar showed missing plane may have turned back: Malaysia military
- Missing Malaysian jet may have disintegrated in mid-air: source |
- Malaysian plane presumed crashed; questions over false IDs |
- Merkel raps Putin as Russian forces tighten grip on Crimea |